Evidence map›Paper›PMID 37528739›Full record

ArticleHLA2024

Exceptional diversity of KIR and HLA class I in Egypt.

Gonzalo Montero-Martin, Katherine M Kichula, Maneesh K Misra, Luciana de Brito Vargas, Wesley M Marin, Jill A Hollenbach, Marcelo A Fernández-Viña, Sally Elfishawi, Paul J Norman

Open access · hybridAbstract read
In one paragraph

Article in HLA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Gonzalo Montero-MartinStanford Blood Center, Department of Pathology, Stanford University, Stanford, California, USA.
Katherine M KichulaDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Maneesh K MisraDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-3757-3326
Luciana de Brito VargasDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Wesley M MarinDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-2334-0396
Jill A HollenbachDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Marcelo A Fernández-ViñaStanford Blood Center, Department of Pathology, Stanford University, Stanford, California, USA.
Sally ElfishawiBMT lab unit, Clinical Pathology Dept., National Cancer Institute, Cairo University, Cairo, Egypt.
Paul J NormanDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0000-0001-8370-7703
University of California, San Francisco · USUniversity of Colorado Denver · USStanford Blood Center · USCairo University · EG

Funding

Insights Into Immune-Related Diseases Born from Population GenomicsU01AI090905 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2010 to 2026
$10.9M
University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
NIAID NIH HHS U01 AI090905NIDDK NIH HHS P30 DK116073NIH HHS NIH P30 DK116073NIH HHS U01 AI090905 (PJN)
6 · The paper itself

Abstract

Genetically determined variation of killer cell immunoglobulin like receptors (KIR) and their HLA class I ligands affects multiple aspects of human health. Their extreme diversity is generated through complex interplay of natural selection for pathogen resistance and reproductive health, combined with demographic structure and dispersal. Despite significant importance to multiple health conditions of differential effect across populations, the nature and extent of immunogenetic diversity is under-studied for many geographic regions. Here, we describe the first high-resolution analysis of KIR and HLA class I combinatorial diversity in Northern Africa. Analysis of 125 healthy unrelated individuals from Cairo in Egypt yielded 186 KIR alleles arranged in 146 distinct centromeric and 79 distinct telomeric haplotypes. The most frequent haplotypes observed were KIR-A, encoding two inhibitory receptors specific for HLA-C, two that are specific for HLA-A and -B, and no activating receptors. Together with 141 alleles of HLA class I, 75 of which encode a KIR ligand, we identified a mean of six distinct interacting pairs of inhibitory KIR and HLA allotypes per individual. We additionally characterize 16 KIR alleles newly identified in the study population. Our findings place Egyptians as one of the most highly diverse populations worldwide, with important implications for transplant matching and studies of immune-mediated diseases.

Indexed as

MultimorbidityNorth African PeopleReceptors, KIRAllelesCross-Sectional StudiesEgyptHaplotypesHumansReceptors, KIRAfricaEgyptHLA class Iimmunogenetic diversityKIR

Identifiers

PMID37528739
PMCPMC11068459
OpenAlexW4385477094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.